Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female mice

Lucas L. Falke, Roel Broekhuizen, Alwin Huitema, Erik Maarseveen, Tri Q. Nguyen, Roel Goldschmeding

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

18 Citaten (Scopus)


A variety of conditional knock-out mice relying on Tamoxifen-driven ERT2/Cre -mediated recombination are available and have been used to study involvement of specific genes in kidney disease. However, recent data suggest that Tamoxifen itself might attenuate fibrosis when administered during experimental models of kidney disease. It has remained unclear whether this still applies also if kidney damage is initiated after a wash-out period has been implemented. Here we report that the commonly applied regimen of administration of 4 alternate day doses of 1mg Tamoxifen per mouse until 14 days prior to start of the actual experiment, in this case the induction of obstructive nephropathy by Unilateral Ureteral Obstruction (UUO), still attenuated fibrosis in female obstructed mouse kidneys, whereas this effect was not seen in male obstructed kidneys. Attenuation of fibrosis was accompanied by a reduction in nuclear ERα positivity despite absence of detectable levels of the active tamoxifen metabolite endoxifen throughout the UUO experiment. In conclusion, these results indicate that the Tamoxifen dosing regimen commonly applied in conditional gene targeting experiments might have prolonged confounding effects in female mice through attenuation of renal fibrosis independent of modulation of the expression of the targeted gene(s).

Originele taal-2Engels
Pagina's (van-tot)205-211
Aantal pagina's7
TijdschriftJournal of Cell Communication and Signaling
Nummer van het tijdschrift2
StatusGepubliceerd - 1 jun. 2017
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female mice'. Samen vormen ze een unieke vingerafdruk.

Citeer dit